Oxford University Hospitals NHS Trust
Gene trial ‘restores sight’
January 17, 2014Research and Development, Sales and Marketing NHS, Oxford University Hospitals NHS Trust, choroideremia, eyes
A UK Phase I trial of a gene therapy designed to restore sight in patients suffering from an inherited form …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
October 26, 2026
